HOERSHOLM, Denmark, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Medical Prognosis Institute A/S (MPI) presents data on its multiple biomarker "DRP" that can predict which indication will be approved by the FDA on the Cambridge Healthtech Institute's Fifth Annual ADAPT Congress (Accelerating Development and Advancing Personalized Therapy) in Boston November 4-6 2013.
Help employers find you! Check out all the jobs and post your resume.
